MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles (NCT03053193)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX)
🩺 Plain-English Summary (8th-Grade Level)
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.
Who can join: Review the eligibility criteria below.
Location: CHS Grandview — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
- MammaPrint, BluePrint, and Full-Genome Testing (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (134 Sites)
Showing the first 25 of 134 sites.
- CHS Grandview — Birmingham, Alabama
- Providence Alaska Medical Center — Anchorage, Alaska
- Arizona Oncology Associates, PC — Phoenix, Arizona
- Arizona Oncology Associates, PC - HOPE — Tucson, Arizona
- Adventist Health - Bakersfield — Bakersfield, California
- Comprehensive Cancer Center at Desert Regional Medical Center — Palm Springs, California
- North Valley Breast Clinic — Redding, California
- UCSF Breast Care Center — San Francisco, California
- Valley Breast Care — Van Nuys, California
- Rocky Mountain Cancer Centers — Aurora, Colorado
- University of Colorado Cancer Center — Aurora, Colorado
- Comprehensive Breast Care of Denver — Denver, Colorado
- Rocky Mountain Cancer Center - Lakewood — Lakewood, Colorado
- Vail Health - Shaw Cancer Center — Vail, Colorado
- St. Mary's Hospital — Waterbury, Connecticut
- Medical Oncology and Hematology Consultants — Newark, Delaware
- Breast Specialists of South Florida — Atlantis, Florida
- JFK Medical Center — Atlantis, Florida
- Boca Raton Regional Hospital — Boca Raton, Florida
- Morton Plant Hospital — Clearwater, Florida
- Halifax Health - Center for Oncology — Daytona Beach, Florida
- Baptist MD Anderson Cancer Center — Jacksonville, Florida
- University of Florida - Jacksonville — Jacksonville, Florida
- St. Vincent Hospital / Mayo Clinic — Jacksonville, Florida
- Lakeland Regional Cancer Center — Lakeland, Florida
📞 Contact the Study Coordinator
Phone: (801) 633-8215
Email: michelle.landon@agendia.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer — Anniston, Alabama
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer — Los Angeles, California
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery — Durham, North Carolina
- TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) — Palo Alto, California
- A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer — Chicago, Illinois
- ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Duarte, California
Explore by condition: All Breast Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.